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Abstract
Background: Meningothelial cells (MECs) are the cellular components of the meninges enveloping the brain. Although
MECs are not fully understood, several functions of these cells have been described. The presence of desmosomes and tight
junctions between MECs hints towards a barrier function protecting the brain. In addition, MECs perform endocytosis and,
by the secretion of cytokines, are involved in immunological processes in the brain. However, little is known about the
influence of pathological conditions on MEC function; e.g., during diseases associated with elevated intracranial pressure,
hypoxia or increased oxidative stress.
Methods: We studied the effect of elevated pressure, hypoxia, and oxidative stress on immortalized human as well as
primary porcine MECs. We used MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) bioreduction assays to assess the proliferation of MECs in response to treatment and compared to untreated
control cells. To assess endocytotic activity, the uptake of fluorescently labeled latex beads was analyzed by fluorescence
microscopy.
Results: We found that exposure of MECs to elevated pressure caused significant cellular proliferation and a dramatic
decrease in endocytotic activity. In addition, mild oxidative stress severely inhibited endocytosis.
Conclusion: Elevated pressure and oxidative stress impact MEC physiology and might therefore influence the
microenvironment of the subarachnoid space and thus the cerebrospinal fluid within this compartment with potential
negative impact on neuronal function.
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Introduction
The meninges cover and protect the brain and its ‘‘appendices’’,
the optic nerves. Whereas the dura mater forms the outer layer,
the arachnoid and the pia mater form the inner layers of the
meninges, with the pia mater facing the brain tissue. The space
between the arachnoid and pia mater is the cerebrospinal fluid
(CSF) filled subarachnoid space. The arachnoid, the pia mater as
well as the arachnoid trabeculae and septae traversing the
subarachnoid space are lined with meningothelial cells. Thus,
these cells surround the CSF-filled subarachnoid space, providing
a barrier between CSF and neuronal tissue on one side and
between CSF and circulation on the other. As such, MECs share
various features with other cell types with similar function such as
vascular endothelial cells that form the blood-brain barrier. These
features include the formation of tight cell-cell contacts such as
desmosomes [1] and/or tight junctions [2] leading to a firm
cellular layer that restricts free diffusion of substances between the
CSF and the brain tissue. In addition, they were shown to actively
produce and secret cytokines [3] and they are involved in the
production of L-PGDS (lipocalin-type prostaglandin D2 synthase
or b-trace protein), a multifunctional protein of the CSF [4,5]. In
addition, MECs are known to perform endocytosis [6]. However,
MECs are still largely unexplored and their reaction to
pathological conditions as well as a potential role during disease
is not well understood.
Several diseases of the central nervous system, such as brain
tumors, cranial vein occlusions, pseudotumor cerebri or menin-
gitis, lead to increased intracranial pressure that sometimes is
associated with oxidative stress or hypoxia [7,8,9]. This increase in
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       3pressure might have an influence on MECs through either
mechanical stress or biochemical mechanisms mediated through
an altered CSF compartment.
Using immortalized human as well as primary porcine MECs,
we addressed the question of whether certain stress conditions such
as elevated pressure and oxidative stress lead to changes in MEC
proliferation or endocytotic activity.
Results
Pressure dependent proliferation rate
To study the effect of pressure on MECs, we exposed
immortalized human as well as porcine MECs to elevated pressure
and compared them with control cells incubated at ambient
pressure, with ambient pressure meaning atmospheric pressure
and elevated pressure meaning a pressure 30 mmHg above
atmospheric pressure. We found that incubation of Ben-Men-I
cells [10] for 2 days under 30 mmHg elevated pressure resulted in
a 20% increase in their proliferation compared with cells
incubated at ambient pressure as measured using MTS assays
(Figure 1A). To exclude effects of gas-mixture composition and
other chamber-related parameters, we performed the same
experiment with cells inside the pressure chamber and gas
application set to 0 mmHg additional pressure. We did not find
a statistically significant difference between cells inside and outside
the non-pressurized pressure chamber, consistent with the
conclusion that additional pressure and not other effects of the
pressure chamber setup caused the observed proliferation of the
MECs (data not shown). To further establish the proliferation-
enhancing effect of elevated pressure on MECs, we also treated
primary porcine MECs [11] prepared from optic nerve sheaths
(PMECs) with elevated pressure. As observed for immortalized
Ben-Men-I cells, elevated pressure caused enhanced proliferation
in PMECs as well (Figure 1B).
Pressure impacts endocytosis by MECs
To analyze endocytosis by MECs, the uptake of fluorescently-
labeled latex particles was analyzed by fluorescence microscopy,
scored visually, and the results compared with those of untreated
control cells. Ben-Men-I cells (Figure 2A) and, to a somewhat
lesser degree, PMECs (Figure 2B) exposed to elevated pressure lost
their high endocytotic activity. Whereas about 60% of MECs
exposed to ambient pressure displayed a high latex bead load,
about 40% of cells exposed to high pressure displayed a high bead
load.
MEC proliferation and endocytosis under hypoxic
conditions
After exposing Ben-Men-I cells and PMECs to hypoxic
conditions, we found that cellular survival was slightly diminished
by hypoxia in Ben-Men-I cells, whereas survival of PMECs was
unaffected as assessed by MTS assay (Figure 3A and C). In
addition, the endocytotic activity in both cell types (Figure 3B and
D) was not significantly affected under these conditions.
Oxidative stress impacts MEC proliferation and
endocytosis
To study the effect of oxidative stress on the proliferation and
endocytosis of MECs, Ben-Men-I and PMECs were exposed to
rotenone, an inhibitor of the mitochondrial electron transport
chain complex I known to cause the production of reactive
oxygen species [12]. Upon this treatment, MECs showed a dose-
dependent loss of viability in response to rotenone compared with
control cells. Although high concentrations of rotenone (20 mM)
reduced the viability of Ben-Men-I cells to around 70% and of
PMECs to around 50%, low concentrations (0.05 to 0.1 mM)
had virtually no effect on cell proliferation. However, even
concentrations of rotenone well below toxic levels (0.05 mM)
caused a severe decline of endocytotic activity in Ben-Men-I cells
(Figure 4B), whereas PMECs were less sensitive to rotenone
treatment and maintained endocytosis under these conditions
(Figure 4D).
Discussion
The localization of MECs at the interface between CSF and
neuronal tissue implies an important function for these cells in
maintaining brain function; however, the role of MECs is far from
being understood, and the cross-talk between MECs and the CSF
compartment is not well explored. In this study, we examined
whether or not conditions encountered by MECs in the course of
certain diseases causing elevated intracranial pressure, hypoxic
conditions or increased oxidative stress might influence the
function of these cells.
As elevated pressure in the range of 30 to 50 mmHg was found
to influence a variety of cellular function in vivo and in vitro
Figure 1. Biomechanical stress induces MEC proliferation.
Proliferation of Ben-Men-I cells (A) and primary porcine MECs (B)
exposed to elevated and ambient pressure for 2 days. Proliferation of
Ben-Men-I cells and PMECs increased in all cell concentration groups
that were exposed to elevated pressure compared to control cells
cultivated under ambient pressure conditions (shown is a representa-
tive result of three independent experiments; error bars represent SD;
Student’s t-test: p,0.01, marked with ** for highly significant).
doi:10.1371/journal.pone.0020142.g001
Reaction of MECs to Pathological Conditions
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[7,8,9], we first asked if meningothelial cells react to this
biomechanical stress. We focused on 30 mmHg as elevated
pressure condition based on the difference between normal
intracranial (around 10 mmHg) and severely elevated intracranial
pressure (above 40 mmHg). We used ambient pressure as control
treatment instead of a normal intracranial pressure of 10 mmHg,
since the pressure difference and not the absolute pressure is most
likely sensed by the cell with the our cultured cells adapted to
ambient pressure.
We observed two distinct effects in response to elevated
pressure: (A) increased proliferation of MECs and (B) reduced
endocytosis both in immortalized human and primary porcine
MECs. The fact that enhanced proliferation as well as reduced
endocytosis was evident in two unrelated cell cultures from
different organisms argues for a general effect of elevated pressure
on MECs.
The observation of increased proliferation of MECs exposed to
elevated pressure suggests an attempt by the cells to maintain
integrity of the meninges in the face of mechanical stress.
Figure 2. Endocytotic function of MECs is impacted by elevated pressure. Ben-Men-I cells (A) or PMECs (B) were treated with elevated
pressure for two days and fluorescent latex beads were added to assess endocytotic activity by fluorescence microscopy (.100 cells scored/
condition). Ben-Men-I cells (Student’s t-test: p,0.01, marked with ** for highly significant) as well as PMECs (Student’s t-test: p,0.05, marked with *
for significant) showed a significant decrease in endocytotic activity after pressure treatment compared to control treated cells (shown is a
representative result of three independent experiments; error bars represent SD).
doi:10.1371/journal.pone.0020142.g002
Figure 3. Hypoxia does not impact MEC function. Ben-Men-I cells and PMECs were incubated under limited oxygen conditions (1% O2) and
compared to cells cultivated under normoxia. Cellular viability was only slightly impacted by this treatment in Ben-Men-I (A – representative result
shown of three independent experiments; error bars represent SD; Student’s t-test: p,0.05, marked with *) but not significantly in PMECs (C, marked
with n.s. for not significant). Evaluation of endocytotic activity by scoring fluorescent latex bead uptake did not reveal a significant difference after
hypoxia in Ben-Men-I cells (B, marked with n.s. for not significant) or PMECs (D, marked with n.s. for not significant).
doi:10.1371/journal.pone.0020142.g003
Reaction of MECs to Pathological Conditions
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20142However, proliferation of MECs can become deleterious at sites of
confined CSF space, such as the subarachnoid space of the optic
nerve [16], as the width of the subarachnoid space here measures
only about 0.3 mm and is further restricted through numerous
trabeculae and septa. Thickening of the arachnoid or the pia
mater in such a region through MEC proliferation might obstruct
the flow of CSF and might, in effect, lead to CSF compartmen-
talization. It is conceivable that this, in turn, might negatively
influence CSF composition and, therefore, might further harm
MECs or even impact neuronal function. Interestingly, impair-
ment of CSF dynamics has been reported in patients with
papilledema [17], and significant proliferation of MECs has been
reported in a post-mortem study in glaucoma patients [18],
pointing to a pathophysiological role of these cells in a
neurodegenerative disorder.
This impact of MECs on CSF might not be limited to the
mechanical obstruction of CSF flow due to unwanted prolifera-
tion. Based on the observation that MECs are actively ingesting
large quantities of particles, a role in clearing waste products from
the CSF through endocytosis by MECs is conceivable. Our finding
that elevated pressure decreased endocytosis suggests that such a
CSF clearing function of MECs might be also decreased in
diseases associated with elevated intracranial pressure. And since
elevated pressure causes increased proliferation and down-
regulates endocytosis, both proliferation and decreased endocyto-
sis might cause synergistically diminished CSF turnover in affected
areas. This decrease of CSF turnover might, in addition, be
enhanced by accompanying oxidative stress. Oxidative stress in
the CSF compartment is believed to be involved in the
pathogenesis of various diseases including Alzheimer disease [19]
and glaucoma [20]. How endocytosis is affected by oxidative stress
in our meningothelial cell model remains unclear, especially since
a difference in the reaction to oxidative stress between immortal-
ized human and primary porcine MECs is noted that might be
attributable to a different rotenone sensitivity of these cells;
however, the amount of rotenone used to induce oxidative stress in
MECs in our study was well below lethal levels as assessed by
proliferation assays. We therefore consider a general toxic effect of
rotenone unlikely and favor a more direct mechanism by which
reactive oxygen species specifically interfere with the endocytotic
machinery. Together with the above discussed MEC proliferation,
the drop in endocytosis activity under oxidative stress conditions
Figure 4. Oxidative stress impairs MEC function. Ben-Men-I cells (A; error bars represent +SEM; ANOVA p,0.01, Tukey’s HSD post-hoc test see
Figure S1A) (5610
4 cells/ml) or PMECs (C; error bars represent +SEM; ANOVA p,0.01, Tukey’s HSD post-hoc test see Figure S1B) were treated with
varying concentrations of the complex I inhibitor rotenone (0–20 mM) for 24 hours to induce oxidative stress. Oxidative damage resulting in
decreased viability was measured using MTS. The impact of oxidative stress on MEC function in terms of endocytosis was analyzed by scoring
fluorescent latex bead uptake following treatment with different concentrations (0, 0.05 and 0.75 mM) of rotenone. Intensity of latex beads engulfed
by Ben-Men-I cells (B; .100 cells/condition; error bars represent SD of three independent counts; Student’s t-test: p,0.05; marked with * for
significant) or PMECs (D; .100 cells/condition; error bars represent SD of three independent counts; Student’s t-test: p.0.05; marked with n.s. for not
significant) decreases with increasing of rotenone concentration where Ben-Men-I cells display a high sensitivity towards rotenone with a reduction in
endocytosis at low, non toxic rotenone concentrations while PMECs are more resistant to oxidative stress and maintain their rate of endocytosis.
doi:10.1371/journal.pone.0020142.g004
Reaction of MECs to Pathological Conditions
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Although MEC proliferation might decrease the flow of CSF
through certain areas, possibly causing waste product accumula-
tion, diminished endocytosis not only due to increased pressure
but also to oxidative stress might then under these conditions
hamper waste removal by MECs. Interestingly and in contrast to
pressure and oxidative stress, hypoxic conditions did not influence
this potential waste removal mechanism in both analyzed cell
models although immortalized human MECs showed a slight drop
in proliferation while porcine MECs were not affected by low
oxygen tension. These data point to a high resistance of MECs
towards hypoxia and their ability to maintain CSF clearance
under these conditions while elevated pressure as well as oxidative
stress is less well tolerated.
Taken together, meningothelial cells provide important shield-
ing function to the brain. This study sheds light on the interplay
between MECs and their surroundings and points to possible
connections between MEC function and pathological processes
suggesting a more active role for these cells in maintaining brain
function as previously appreciated.
Materials and Methods
Cell culture and treatment
Human WHO grade I meningioma-derived, hTERT-immor-
talized Ben-Men-I cells (DMSZ, Braunschweig) [10] were cultured
in DMEM supplemented with 10% fetal calf serum, 2 mM L-
glutamine, and 1 mM sodium pyruvate (Sigma-Aldrich, Buchs).
Primary porcine meningothelial cells (PMECs) were cultured as
previously described [11]. In short, PMECs were scraped from the
inside of the optic nerve sheath from porcine eyes obtained fresh
from the local slaughterhouse. After outgrowth, contaminating
fibroblasts were removed using magnetic anti-fibroblast beads
(Miltenyi, Bergisch Gladbach).
To induce oxidative stress, cells were treated with varying
concentrations (0–20 mM) of the mitochondrial complex I inhibitor
rotenone or with DMSO (Sigma-Aldrich, Buchs) as a vector control.
Pressure treatment was performed in a Plexiglas box with two
openings inside a normal cell culture incubator. One opening was
connected to a pressurized gas cylinder (certified: 5% CO2,2 1 %O 2,
74% N2) and the other opening was connected to a tube placed inside
a 40 cm water column (equals 30 mmHg) to act as pressure regulator.
Before entering the pressure chamber, the gas mixture was humidified
and pre-warmed by slowly bubbling through a gas wash bottle kept
inside the incubator. The gas flow was set to around one bubble per
second as monitored at the tubing outlet in the water column.
For hypoxic conditions, cells were cultivated in an incubator
under 1% oxygen and 5% CO2.
Cell proliferation assay
Cells were seeded at indicated densities into 96 well plates and
grown under the indicated conditions. To determine cellular
viability, we incubated samples with [3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt
(MTS) (CellTiter 96 Aqueous One Solution Cell Proliferation
Assay – Promega, Du ¨bendorf) according to the manufacturer’s
instructions. Cell proliferation was calculated by Atreatment/
Acontrol6100%, where A represents the absorbance recorded at
490 nm.
Endocytosis assay
Cells wereseeded at 60,000 cells/well into 12 wellplates (Sarstedt,
Sevelen)on top of a coverslipglass,grown inDMEMwith 10% fetal
calf serum, 2 mM L-glutamine, 1 mM sodium pyruvate (Sigma-
Aldrich, Buchs) and treated for 1 day with the mitochondrial
electron transport chain inhibitor rotenone at increasing concentra-
tions (0–20 mM) to induce oxidative stress or in a specialized
chamber at elevated and ambient pressure conditions for 2 days.
Fluorescently-labeled latex beads (1 mm diameter, Sigma-Aldrich,
Buchs) were added to the medium and the cells were incubated for
another 24 hours, after which the cells were removed from the
medium, fixed in 4% paraformaldehyde in PBS (Pierce) for 30 min,
permeabilized with 0.15% Triton X-100 in PBS for 15 min, blocked
with PBS containing 10% bovine serum albumin for 1 hour, and
then washed with PBS. Cells were counterstained with DAPI for
3 minutes, mounted on glass slides, and observed using a
fluorescence microscope (Olympus B651, Japan) to determine the
intensity of the uptake of latex beads by visual examination. Cells
werecategorized visually according to theamount oflatexbeadsinto
‘‘high load’’ for cells with a large amount of latex beads (up to 200
beads/cell) and into ‘‘low load’’ for cells with a small amount of
beads inside the cytosol (around 20 beads/cells). Due to the large
amount of ingested beads per cell, the beads were not counted
individually, but were categorized by the observer.
Statistical analysis
Data were analyzed by Student’s t-test or ANOVA with Tukey’s
HSD (Honestly Significant Difference) post-hoc test. p-val-
ues,0.05 were considered significant and were marked with *,
while p-values,0.01 were considered highly significant and were
marked with **. No significant difference (p.0.05) was marked
with n.s. for not significant. Error bars represent standard
deviation (SD) unless stated otherwise.
Supporting Information
Figure S1 Statistical analysis of MEC sensitivity to
rotenone treatment. ANOVA analysis with Tukey’s HSD
post-hoc test for (A) Figure 4A or (B) Figure 4C. The analysis was
performed using Statistica software.
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